References

• 2003Economic Costs of Diabetes in the U.S. in 20024,147 cited
• 2008Economic Costs of Diabetes in the U.S. in 20071,360 cited
• 2007The burden of disease and injury in Australia 20031,299 cited
• 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,181 cited
• 1998An Introduction to Markov Modelling for Economic Evaluation960 cited
• 2005The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance703 cited
• 2004A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)615 cited
• 2003Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program358 cited
• 2005Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes318 cited
• 2003Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes262 cited
• 2007Diabetes Care: Moving (a Little) in the Winds of Change165 cited
• 2004Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom128 cited
• 2000